{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:14:00Z","timestamp":1763003640498,"version":"3.45.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270767"],"award-info":[{"award-number":["82270767"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jtct.2022.10.021","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T18:26:47Z","timestamp":1667154407000},"page":"110.e1-110.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics of Engraftment Syndrome following Autologous Stem Cell Transplantation in Light Chain Amyloidosis with Renal Involvement"],"prefix":"10.1016","volume":"29","author":[{"given":"Fujia","family":"Miao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guisheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-9426","authenticated-orcid":false,"given":"Xianghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.10.021_bib0001","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.bbmt.2015.08.030","article-title":"Engraftment syndrome after autologous stem cell transplantation: an update unifying the definition and management approach","volume":"21","author":"Cornell","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0002","doi-asserted-by":"crossref","first-page":"e13875","DOI":"10.1111\/ctr.13875","article-title":"Engraftment syndrome following hematopoietic stem cell transplant: a review of the literature","volume":"34","author":"Grant","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0003","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12288-017-0899-4","article-title":"Engraftment syndrome: clinical features and predictive factors in autologous stem cell transplant","volume":"34","author":"Sheth","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.jtct.2022.10.021_bib0004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.bmt.1703855","article-title":"Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria","volume":"31","author":"Maiolino","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0006","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/bmt.2009.363","article-title":"Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center","volume":"45","author":"Carreras","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0007","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.22202","article-title":"Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis","volume":"87","author":"Irazabal","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.10.021_bib0008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hon.2813","article-title":"Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation","volume":"39","author":"Betticher","year":"2021","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.10.021_bib0009","doi-asserted-by":"crossref","unstructured":"Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005;79:319-328.","DOI":"10.1002\/ajh.20381"},{"key":"10.1016\/j.jtct.2022.10.021_bib0010","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.10.021_bib0011","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2017-02-767475","article-title":"AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis","volume":"130","author":"Dittrich","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.10.021_bib0012","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.10.021_bib0013","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bmt.2014.296","article-title":"Engraftment syndrome: double-edged sword of hematopoietic cell transplants","volume":"50","author":"Spitzer","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0014","first-page":"114","article-title":"Engraftment syndrome: a retrospective analysis of the experience at a tertiary care institute","volume":"1","author":"Pramanik","year":"2019","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.jtct.2022.10.021_bib0015","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41409-018-0189-2","article-title":"Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation","volume":"53","author":"Gutierr\u00e9z-Garc\u00eda","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0016","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1016\/j.bbmt.2019.05.035","article-title":"Autologous stem cell transplantation for multiple myeloma: growth factor matters","volume":"25","author":"Chen","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1702155","article-title":"An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose","volume":"25","author":"Edenfield","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0018","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.bbmt.2013.06.017","article-title":"Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma","volume":"19","author":"Cornell","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0019","first-page":"943","article-title":"Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation","volume":"18","author":"Ravoet","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0020","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/10428190500086121","article-title":"Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation","volume":"46","author":"Fassas","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.10.021_bib0021","doi-asserted-by":"crossref","first-page":"e13797","DOI":"10.1111\/ctr.13797","article-title":"Postautologous stem cell transplantation engraftment syndrome: improved treatment and outcomes","volume":"34","author":"Liu","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0022","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10428194.2018.1466295","article-title":"Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation","volume":"60","author":"Mori","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.10.021_bib0023","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/s41409-020-0947-9","article-title":"The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium","volume":"55","author":"Martinez-Sanchez","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ckj\/sfu117","article-title":"The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients","volume":"8","author":"Huang","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jtct.2022.10.021_bib0025","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1523-1755.2003.00762.x","article-title":"C-reactive protein is associated with renal function abnormalities in a non-diabetic population","volume":"63","author":"Stuveling","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jtct.2022.10.021_bib0026","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ndt\/gfq471","article-title":"Inflammation, kidney function and albuminuria in the Framingham Offspring cohort","volume":"26","author":"Upadhyay","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jtct.2022.10.021_bib0028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-140-1-200401060-00006","article-title":"The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease","volume":"140","author":"Muntner","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2022.10.021_bib0029","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/1756-0500-5-537","article-title":"Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study","volume":"5","author":"Nerpin","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jtct.2022.10.021_bib0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/13506129.2019.1645001","article-title":"Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis","volume":"26","author":"Badar","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.jtct.2022.10.021_bib0031","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbmt.2009.10.022","article-title":"Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease","volume":"16","author":"Patel","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0032","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbmt.2013.01.014","article-title":"Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease","volume":"19","author":"Park","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0033","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ajh.23716","article-title":"Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults","volume":"89","author":"Omer","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.10.021_bib0034","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/bmt.2012.279","article-title":"Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00277-013-1981-0","article-title":"Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation","volume":"93","author":"Brownback","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2022.10.021_bib0036","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbmt.2010.09.013","article-title":"Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome","volume":"17","author":"Koreth","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0037","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbmt.2015.12.016","article-title":"Cytokine profile of engraftment syndrome in pediatric hematopoietic stem cell transplant recipients","volume":"22","author":"Khandelwal","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.021_bib0038","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.bbmt.2017.07.020","article-title":"Cytokine profiles of pre-engraftment syndrome after single-unit cord blood transplantation for adult patients","volume":"23","author":"Konuma","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722017146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722017146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:09:50Z","timestamp":1763003390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722017146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2666636722017146"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.10.021","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Engraftment Syndrome following Autologous Stem Cell Transplantation in Light Chain Amyloidosis with Renal Involvement","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}